Next Article in Journal
Post-Translational Modification and Secretion of Azelaic Acid Induced 1 (AZI1), a Hybrid Proline-Rich Protein from Arabidopsis
Next Article in Special Issue
Alternative Splicing in Adhesion- and Motility-Related Genes in Breast Cancer
Previous Article in Journal
Aneurysm miRNA Signature Differs, Depending on Disease Localization and Morphology
Previous Article in Special Issue
Meta-Analysis of Multiple Sclerosis Microarray Data Reveals Dysregulation in RNA Splicing Regulatory Genes
Open AccessArticle

Altered Pre-mRNA Splicing Caused by a Novel Intronic Mutation c.1443+5G>A in the Dihydropyrimidinase (DPYS) Gene

Department of Pediatrics, Fujita Health University School of Medicine, Toyoake 470-1192, Japan
Laboratory Genetic Metabolic Diseases, Academic Medical Center, Amsterdam 1105 AZ, The Netherlands
Department of Research and Development, MILS International, Kanazawa 921-8105, Japan
Department of Neurology, Beijing Children’s Hospital Affiliated to Capital University of Medical Sciences, Beijing 100045, China
Department of Chemistry-BMC, Uppsala University, Uppsala 75123, Sweden
Author to whom correspondence should be addressed.
Academic Editor: Jianhua Zhu
Int. J. Mol. Sci. 2016, 17(1), 86;
Received: 20 November 2015 / Revised: 28 December 2015 / Accepted: 4 January 2016 / Published: 12 January 2016
(This article belongs to the Special Issue Pre-mRNA Splicing 2015)
Dihydropyrimidinase (DHP) deficiency is an autosomal recessive disease caused by mutations in the DPYS gene. Patients present with highly elevated levels of dihydrouracil and dihydrothymine in their urine, blood and cerebrospinal fluid. The analysis of the effect of mutations in DPYS on pre-mRNA splicing is hampered by the fact that DHP is primarily expressed in liver and kidney cells. The minigene approach can detect mRNA splicing aberrations using cells that do not express the endogenous mRNA. We have used a minigene-based approach to analyze the effects of a presumptive pre-mRNA splicing mutation in two newly identified Chinese pediatric patients with DHP deficiency. Mutation analysis of DPYS showed that both patients were compound heterozygous for a novel intronic mutation c.1443+5G>A in intron 8 and a previously described missense mutation c.1001A>G (p.Q334R) in exon 6. Wild-type and the mutated minigene constructs, containing exons 7, 8 and 9 of DPYS, yielded different splicing products after expression in HEK293 cells. The c.1443+5G>A mutation resulted in altered pre-mRNA splicing of the DPYS minigene construct with full skipping of exon 8. Analysis of the DHP crystal structure showed that the deletion of exon 8 severely affects folding, stability and homooligomerization of the enzyme as well as disruption of the catalytic site. Thus, the analysis suggests that the c.1443+5G>A mutation results in aberrant splicing of the pre-mRNA encoding DHP, underlying the DHP deficiency in two unrelated Chinese patients. View Full-Text
Keywords: dihydropyrimidinase; DPYS; splicing; minigene dihydropyrimidinase; DPYS; splicing; minigene
Show Figures

Graphical abstract

MDPI and ACS Style

Nakajima, Y.; Meijer, J.; Zhang, C.; Wang, X.; Kondo, T.; Ito, T.; Dobritzsch, D.; Van Kuilenburg, A.B.P. Altered Pre-mRNA Splicing Caused by a Novel Intronic Mutation c.1443+5G>A in the Dihydropyrimidinase (DPYS) Gene. Int. J. Mol. Sci. 2016, 17, 86.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop